Why It Matters The rise of highly pathogenic avian influenza (HPAI) strains like H5N1, their spread to livestock, and increasing zoonotic infections in the U.S. has underscored the need for rapid, accurate immune assay infrastructure. BARDA’s RRPV initiative calls for laboratories with existing capabilities to function as a central immunoassay laboratory and perform quality-assured immunoassays […]
Key Takeaways from the April 2025 Executive Order On April 2, 2025, President Trump issued an Executive Order titled “Modernizing Defense Acquisitions and Spurring Innovation in the Defense Industrial Base.” This directive signals a major shift in how the Department of Defense (DoD) acquires technology, emphasizing speed, flexibility, and inclusion of non-traditional contractors. 1. Streamlining
April 2025 Executive Order Read More »
NSCEB Final Report: Charting the Future of Biotechnology in America The National Security Commission on Emerging Biotechnology (NSCEB) has released its final report, “Charting the Future of Biotechnology: An Action Plan for American Security and Prosperity.” This document outlines a strategic roadmap emphasizing the need for the United States to significantly increase investment—recommending a minimum
Charting the Future of Biotechnology Read More »
Strengthening America’s Defense: The Defense Innovation Unit’s Blue Manufacturing Initiative In an era where rapid technological advancement is crucial for national security, the Defense Innovation Unit (DIU) has launched the Blue Manufacturing Initiative. This strategic program aims tobolster the United States defense manufacturing capabilities by fostering partnerships with trustedadvanced manufacturing companies. Addressing Critical Challenges The
DIU Launches Blue Manufacturing Marketplace Read More »
The Foci of PROSPR ARPA-H-SOL-25-125, PROSPR The PROSPR solicitation outlines a comprehensive, multi-year program structured around the development, validation, and deployment of novel health technologies. The program is divided into three primary technical areas (TAs), each addressing a critical component of healthspan extension: TA1 focuses on developing a PROSPR Intrinsic Capacity (IC) score that quantifies
Proactive Solutions for Prolonging Resilience Opportunity Announcement Read More »
DARPA_PS_25-05_R3_ERIS_Announcement_1_Feb_2025_ (3) Overview The Defense Advanced Research Projects Agency (DARPA) is the U.S. Department of Defense’s premier agency for driving technological innovation and funding breakthrough capabilities to ensure national security. Known for pioneering technologies like the internet and GPS, DARPA focuses on high-risk, high-reward research that can lead to the development of critical strategic products.
DARPA’s ERIS Marketplace Read More »
Broad Agency Announcement Information Innovation Office Securing Artificial Intelligence for Battlefield Effective Robustness (SABER) – HR001125S0009 Securing AI on the Battlefield: DARPA’s SABER Initiative In an era where artificial intelligence (AI) is becoming an integral part of military operations, ensuring its security and resilience is paramount. The Defense Advanced Research Projects Agency (DARPA) has launched
DARPA’s SABER Initiative to Secure AI on the Battlefield Read More »
Overview The Advanced Research Projects Agency for Health (ARPA-H) is dedicated to accelerating transformative health solutions by tackling some of the most pressing challenges in biomedical and healthcare innovation. As part of this mission, ARPA-H has launched Mission Office Innovative Solutions Openings (ISOs) that promote the development of health technologies that lie outside of the
ARPA-H Mission Office Innovative Solutions Openings (ISOs) Read More »
What is the ERIS? The Expedited Research Implementation Series (ERIS) is a cutting-edge initiative launched by the Defense Advanced Research Projects Agency (DARPA) in partnership with the Applied Research Institute (ARI). ERIS serves as a digital marketplace that facilitates the submission, assessment, and acquisition of breakthrough technologies through rapid acquisition pathways. This unique initiative enables
Expedited Research Implementation Series (ERIS) Read More »
Overview In a major development for the biomedical research community, the National Institutes of Health (NIH) has officially acknowledged that its recent funding freeze was unlawful and has announced the resumption of grant distributions. This decision follows weeks of controversy and legal challenges, during which research institutions, universities, and lawmakers criticized the abrupt halt in
NIH Admits Funding Freeze Was Illegal, Resumes Issuing Grants Read More »
RAPID_SOL_25_119_FINAL Overview The Advanced Research Projects Agency for Health (ARPA-H) recently announced the newly approved program for Rare disease AI/ML for Precision Integrated Diagnostics (RAPID). The RAPID program aims to significantly improve outcomes for people with rare diseases by reducing diagnostic delays by ≥50%, decreasing misdiagnosis rates, and expanding access to diagnostics. Beyond benefitting the treatment experience of
RAPID Solicitation Read More »
Court Blocks NIH Cap on Indirect Cost Rates for Government Contracts In a significant development for research institutions and federal contractors, a federal judge has temporarily blocked the National Institutes of Health (NIH) from enforcing its cap on indirect cost rates. This decision comes as a result of a temporary restraining order (TRO) issued by
Court Blocks NIH Cap on Indirect Cost Rates Read More »
